- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Vivanza Biosciences Limited has clarified a typographical error in its financial results notes. The Audit Committee and Board meeting date was incorrectly stated as May 9 instead of May 12 in both standalone and consolidated financial results for the quarter and year ended March 31, 2025. Apart from this correction, there are no changes to the submitted results. The revised financial statements have been shared for reference. This correction ensures accurate documentation without impacting the company's reported performance.